Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

交易中 01-13 09:43:21 EST

1.17

-0.02

-1.67%

最高1.18	最低1.16	成交量5,040
今开1.18	昨收1.19	日振幅1.62%
总市值1,260万	流通市值1,254万	总股本1,076万
成交额5,913	换手率0.05%	流通股本1,071万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":1.1701,"timestamp":1768315389758,"preClose":1.19,"halted":0,"volume":5040,"delay":0,"floatShares":10714600,"shares":10764400,"eps":-2.15,"marketStatus":"交易中","change":-0.0199,"latestTime":"01-13 09:43:21 EST","open":1.18,"high":1.18,"low":1.1607,"amount":5913.256608,"amplitude":0.016218,"askPrice":1.18,"askSize":45,"bidPrice":1.17,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.15,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.19,"preHourTrading":{"tag":"盘前","latestPrice":1.1952,"preClose":1.19,"latestTime":"08:40 EST","volume":169,"amount":199.64198149999999,"timestamp":1768311613346},"postHourTrading":{"tag":"盘后","latestPrice":1.15,"preClose":1.19,"latestTime":"19:57 EST","volume":1459,"amount":1678.0655,"timestamp":1768265872641},"volumeRatio":0.479435,"impliedVol":2.2612,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO","defaultTab":"news","newsList":[{"id":"2601396103","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘快速拉升6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601396103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601396103?lang=zh_cn&edition=full","pubTime":"2026-01-08 03:52","pubTimestamp":1767815556,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日03时52分，Phio Pharmaceuticals Corp.股票出现异动，股价快速拉升6.09%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为2.28%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803523797a135a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803523797a135a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2593443084","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下跌5.45%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593443084?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:33","pubTimestamp":1766500433,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时33分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅跳水5.45%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Genenta Science Spa、Neurosense Therapeutics Ltd.涨幅较大，Lexaria Bioscience Corp.、Pmgc Holdings Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为61.95%、17.90%、15.79%，振幅较大的相关个股有Chemomab Therapeutics Ltd、健永生技、Radiopharm Theranostics Limited，振幅分别为15.46%、13.73%、10.88%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223353a46f5a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223353a46f5a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"1182020903","title":"Phio Pharmaceuticals Corp - Ph-762在所有入组患者的每个增量剂量组中均表现良好耐受","url":"https://stock-news.laohu8.com/highlight/detail?id=1182020903","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182020903?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:57","pubTimestamp":1766498237,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp - Ph-762在所有入组患者的每个增量剂量组中均表现良好耐受","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"1181711469","title":"Phio Pharmaceuticals - 持续推进2026年可商业化药品的交付","url":"https://stock-news.laohu8.com/highlight/detail?id=1181711469","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181711469?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:56","pubTimestamp":1766498178,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals - 持续推进2026年可商业化药品的交付","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"1165251729","title":"Phio Pharmaceuticals Corp 提交证券交易委员会申请，拟向出售股东增发至多1180万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1165251729","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165251729?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:09","pubTimestamp":1763672950,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp 提交证券交易委员会申请，拟向出售股东增发至多1180万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"1155175320","title":"Phio Pharmaceuticals Corp - 安全委员会对Intasyl Ph-762的最大剂量给予积极评估 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1155175320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155175320?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:10","pubTimestamp":1762175410,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp - 安全委员会对Intasyl Ph-762的最大剂量给予积极评估 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2564360863","title":"Phio Pharmaceuticals Corp.盘中异动 临近收盘股价大涨6.09%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564360863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564360863?lang=zh_cn&edition=full","pubTime":"2025-09-03 03:57","pubTimestamp":1756843028,"startTime":"0","endTime":"0","summary":"北京时间2025年09月03日03时57分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨6.09%。截至发稿，该股报2.09美元/股，成交量5.3041万股，换手率0.93%，振幅3.55%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.60%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903035708a4b04554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903035708a4b04554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2559917960","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559917960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559917960?lang=zh_cn&edition=full","pubTime":"2025-08-15 21:32","pubTimestamp":1755264754,"startTime":"0","endTime":"0","summary":"北京时间2025年08月15日21时32分，Phio Pharmaceuticals Corp.股票出现异动，股价快速跳水5.48%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.25%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815213234a6e865e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815213234a6e865e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2558662771","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558662771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558662771?lang=zh_cn&edition=full","pubTime":"2025-08-12 02:33","pubTimestamp":1754937211,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日02时33分，Phio Pharmaceuticals Corp.股票出现波动，股价快速跳水5.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6136.99%、637.74%、470.97%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812023331a4826d3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812023331a4826d3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2557598922","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘股价大跌6.01%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598922?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:31","pubTimestamp":1754587901,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时31分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下跌6.01%。截至发稿，该股报2.19美元/股，成交量8.1231万股，换手率1.69%，振幅4.48%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.21%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808013142a47b7573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808013142a47b7573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2555024184","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘股价大跌5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555024184","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555024184?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:03","pubTimestamp":1753902211,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时03分，Phio Pharmaceuticals Corp.股票出现波动，股价快速跳水5.12%。截至发稿，该股报2.41美元/股，成交量16.7681万股，换手率3.49%，振幅4.33%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.23%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731030332a46c03b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731030332a46c03b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2554772133","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772133?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:30","pubTimestamp":1753709454,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时30分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下挫5.84%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为214.00%、80.12%、79.81%，振幅较大的相关个股有Celcuity Inc.、Aim Immunotech Inc.、Mersana Therapeutics, Inc.，振幅分别为23.86%、15.47%、8.31%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213054a6c61500&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213054a6c61500&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2517016534","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下挫5.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517016534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517016534?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271425,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下挫5.04%。截至发稿，该股报1.32美元/股，成交量2651股，换手率0.06%，振幅0.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.00%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223025abeb76f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223025abeb76f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2517941652","title":"Phio Pharmaceuticals Corp.盘中异动 急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517941652?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:05","pubTimestamp":1741190746,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时05分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.23%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.31%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000546abe9cdfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306000546abe9cdfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2516608031","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下挫5.30%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608031?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:59","pubTimestamp":1741100396,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时59分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下跌5.30%。截至发稿，该股报1.25美元/股，成交量3.962万股，换手率0.83%，振幅5.30%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.36%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225956a25f0d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225956a25f0d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2516681006","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘股价大跌7.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516681006?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:19","pubTimestamp":1741033151,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时19分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下跌7.75%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4599.47%、213.16%、183.18%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040419119637f9da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040419119637f9da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2514090074","title":"Phio Pharmaceuticals Corp.盘中异动 快速下挫6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090074?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下挫6.01%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为759.92%、468.74%、242.26%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.，振幅分别为20.51%、14.67%、11.73%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223334962ff2df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223334962ff2df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2513560773","title":"Phio Pharmaceuticals Corp.盘中异动 快速跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513560773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513560773?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:37","pubTimestamp":1740411439,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时37分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌5.39%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为210.43%、89.48%、28.02%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242337209891056b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242337209891056b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2512911621","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512911621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512911621?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:25","pubTimestamp":1739910304,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时25分，Phio Pharmaceuticals Corp.股票出现波动，股价快速下跌5.52%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为912.66%、214.83%、173.12%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042504a24af4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042504a24af4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2511694823","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694823?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:23","pubTimestamp":1739546607,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时23分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨5.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.11%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232327abcf127a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232327abcf127a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":0.0625},{"period":"3month","weight":-0.464},{"period":"6month","weight":-0.5},{"period":"1year","weight":-0.2959},{"period":"ytd","weight":0.1333}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.于2011年9月8日在特拉华州注册成立为Galena的全资子公司，以准备该公司计划从Galena分拆上市，该计划已于2012年4月27日完成。自该日起，该公司作为一家独立的上市公司运营。是一家生物技术公司，专注于发现、开发和商业化基于该公司专有的新一代RNA干扰（“RNAi”）平台的创新疗法。由于能够“沉默”或下调特定基因的表达，使用RNAi的治疗药物具有很大的前景。在2011年9月8日之前，该公司的业务作为Galena Biopharma，Inc.（“Galena”或“母公司”）内的非法人部门运营，该公司是该公司的前母公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.028778},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.058261},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.080913},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.07123},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.031751},{"month":6,"riseRate":0.5,"avgChangeRate":-0.004305},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.093442},{"month":8,"riseRate":0.25,"avgChangeRate":-0.042027},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.099086},{"month":10,"riseRate":0.25,"avgChangeRate":-0.134645},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.090172},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.146601}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}